S&P 500   3,980.90 (+0.74%)
DOW   32,429.61 (+0.57%)
QQQ   307.57 (+0.52%)
AAPL   157.96 (+0.36%)
MSFT   271.10 (-0.42%)
META   199.87 (+1.04%)
GOOGL   103.63 (+2.38%)
AMZN   99.62 (+1.95%)
TSLA   194.14 (+5.94%)
NVDA   257.24 (-0.68%)
NIO   9.25 (+5.71%)
BABA   83.14 (+2.64%)
AMD   95.30 (-1.56%)
T   18.49 (+0.00%)
F   11.76 (+5.19%)
MU   58.12 (+0.83%)
CGC   1.97 (+5.91%)
GE   92.43 (+2.79%)
DIS   96.33 (+2.24%)
AMC   4.39 (+2.81%)
PFE   40.56 (-0.61%)
PYPL   75.32 (+2.88%)
NFLX   304.95 (-0.06%)
S&P 500   3,980.90 (+0.74%)
DOW   32,429.61 (+0.57%)
QQQ   307.57 (+0.52%)
AAPL   157.96 (+0.36%)
MSFT   271.10 (-0.42%)
META   199.87 (+1.04%)
GOOGL   103.63 (+2.38%)
AMZN   99.62 (+1.95%)
TSLA   194.14 (+5.94%)
NVDA   257.24 (-0.68%)
NIO   9.25 (+5.71%)
BABA   83.14 (+2.64%)
AMD   95.30 (-1.56%)
T   18.49 (+0.00%)
F   11.76 (+5.19%)
MU   58.12 (+0.83%)
CGC   1.97 (+5.91%)
GE   92.43 (+2.79%)
DIS   96.33 (+2.24%)
AMC   4.39 (+2.81%)
PFE   40.56 (-0.61%)
PYPL   75.32 (+2.88%)
NFLX   304.95 (-0.06%)
S&P 500   3,980.90 (+0.74%)
DOW   32,429.61 (+0.57%)
QQQ   307.57 (+0.52%)
AAPL   157.96 (+0.36%)
MSFT   271.10 (-0.42%)
META   199.87 (+1.04%)
GOOGL   103.63 (+2.38%)
AMZN   99.62 (+1.95%)
TSLA   194.14 (+5.94%)
NVDA   257.24 (-0.68%)
NIO   9.25 (+5.71%)
BABA   83.14 (+2.64%)
AMD   95.30 (-1.56%)
T   18.49 (+0.00%)
F   11.76 (+5.19%)
MU   58.12 (+0.83%)
CGC   1.97 (+5.91%)
GE   92.43 (+2.79%)
DIS   96.33 (+2.24%)
AMC   4.39 (+2.81%)
PFE   40.56 (-0.61%)
PYPL   75.32 (+2.88%)
NFLX   304.95 (-0.06%)
S&P 500   3,980.90 (+0.74%)
DOW   32,429.61 (+0.57%)
QQQ   307.57 (+0.52%)
AAPL   157.96 (+0.36%)
MSFT   271.10 (-0.42%)
META   199.87 (+1.04%)
GOOGL   103.63 (+2.38%)
AMZN   99.62 (+1.95%)
TSLA   194.14 (+5.94%)
NVDA   257.24 (-0.68%)
NIO   9.25 (+5.71%)
BABA   83.14 (+2.64%)
AMD   95.30 (-1.56%)
T   18.49 (+0.00%)
F   11.76 (+5.19%)
MU   58.12 (+0.83%)
CGC   1.97 (+5.91%)
GE   92.43 (+2.79%)
DIS   96.33 (+2.24%)
AMC   4.39 (+2.81%)
PFE   40.56 (-0.61%)
PYPL   75.32 (+2.88%)
NFLX   304.95 (-0.06%)
NASDAQ:ABMD

Abiomed - ABMD Insider Trading & Ownership

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$381.02
▼
$381.02
50-Day Range
$377.20
▼
$381.30
52-Week Range
$219.85
▼
$381.99
Volume
258 shs
Average Volume
611,028 shs
Market Capitalization
$17.18 billion
P/E Ratio
65.47
Dividend Yield
N/A
Price Target
$355.60

Abiomed (NASDAQ:ABMD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$6.30 M

ABMD Insider Buying and Selling by Quarter

Get ABMD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Abiomed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Abiomed Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/4/2022Marc A BeganVPSell2,000$373.71$747,420.0013,785  
11/1/2022Matthew T PlanoVPSell3,544$378.61$1,341,793.8410,270  
11/1/2022Paul ThomasDirectorSell1,000$379.38$379,380.006,357  
8/29/2022Marc A BeganVPSell500$255.95$127,975.0015,785  
8/3/2022Todd A TrappCFOSell1,000$300.00$300,000.0016,927  
5/17/2022Martin P SutterDirectorSell2,000$258.01$516,020.00128,390  
4/4/2022Todd A TrappCFOSell1,000$333.00$333,000.0013,063  
3/31/2022David M WeberCOOSell7,500$340.00$2,550,000.00116,314  
(Data available from 1/1/2013 forward)












ABMD Insider Trading Activity - Frequently Asked Questions

Who is on Abiomed's Insider Roster?

The list of insiders at Abiomed includes Andrew J Greenfield, David M Weber, Dorothy E Puhy, Marc A Began, Martin P Sutter, Matthew T Plano, Michael R Minogue, Paul Thomas, and Todd A Trapp. Learn more on insiders at ABMD.

What percentage of Abiomed stock is owned by insiders?

2.50% of Abiomed stock is owned by insiders. Learn more on ABMD's insider holdings.

Which Abiomed insiders have been selling company stock?

The following insiders have sold ABMD shares in the last 24 months: David M Weber ($3,605,386.28), Marc A Began ($875,395.00), Martin P Sutter ($8,780,447.50), Matthew T Plano ($1,341,793.84), Michael R Minogue ($9,355,950.00), Paul Thomas ($598,680.51), and Todd A Trapp ($992,430.00).

How much insider selling is happening at Abiomed?

Insiders have sold a total of 108,369 Abiomed shares in the last 24 months for a total of $36,577,883.13 sold.

This page (NASDAQ:ABMD) was last updated on 3/21/2023 by MarketBeat.com Staff